Literature DB >> 9399732

Symptomatic conduction system disease in cardiac amyloidosis.

V Mathew1, L J Olson, M A Gertz, D L Hayes.   

Abstract

Symptomatic conduction system disease in cardiac amyloidosis and its management has been reported infrequently. We report our experience of patients with amyloidosis having symptomatic conduction system disease requiring permanent pacemaker implantation.

Entities:  

Mesh：

Year:  1997        PMID： 9399732     DOI： 10.1016/s0002-9149(97)82785-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  14 in total

Review 1.  Transthyretin Cardiac Amyloidosis.

Authors:  Anit K Mankad; Keyur B Shah
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

2.  Syncope in cardiac amyloidosis and chronic ischemic heart disease: A case report.

Authors:  Giacomo Mugnai; Mariantonietta Cicoira; Andrea Rossi; Corrado Vassanelli
Journal:  Exp Clin Cardiol       Date:  2011

3.  Isolated cardiac involvement in primary amyloidosis: presenting as sick sinus syndrome and heart failure.

Authors:  Deepak J Pattanshetty; Pradeep K Bhat; Wendy A Chamberlain; Matthew R Lyons
Journal:  Tex Heart Inst J       Date:  2013

Review 4.  Cardiac Amyloidosis: Diagnosis and Treatment Strategies.

Authors:  Mirela Tuzovic; Eric H Yang; Arnold S Baas; Eugene C Depasquale; Mario C Deng; Daniel Cruz; Gabriel Vorobiof
Journal:  Curr Oncol Rep       Date:  2017-07       Impact factor: 5.075

Review 5.  Natural history and therapy of AL cardiac amyloidosis.

Authors:  Martha Grogan; Angela Dispenzieri
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

6.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

7.  Prevalence and prognostic value of conduction disturbances at the time of diagnosis of cardiac AL amyloidosis.

Authors:  Michele Boldrini; Francesco Salinaro; Roberta Mussinelli; Ambra Raimondi; Alessio Alogna; Francesco Musca; Giovanni Palladini; Giampaolo Merlini; Stefano Perlini
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-01-20       Impact factor: 1.468

8.  An unusual case of cardiac amyloidosis.

Authors:  Brian Garibaldi; David Zaas
Journal:  J Gen Intern Med       Date:  2007-04-20       Impact factor: 5.128

Review 9.  Infiltrative Cardiomyopathies.

Authors:  David Bejar; Paolo C Colombo; Farhana Latif; Melana Yuzefpolskaya
Journal:  Clin Med Insights Cardiol       Date:  2015-07-08

10.  Amiloidosis, a mysterious disease, still underestimated.

Authors:  Mircea Penescu
Journal:  J Med Life       Date:  2008 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.